The UK market for Penicillins and Streptomycins in dosage saw fluctuations from 2013 to 2023, with a high of 14.84 USD per capita in 2014 and a decline to 10.77 USD in 2023. The most significant year-on-year change occurred between 2014 and 2015, with a decline of 3.70%. The compound annual growth rate (CAGR) from 2018 to 2023 was -1.78%, indicating a consistent downward trend in recent years. Key observations over the last two years highlight a decrease of 2.57% from 2022 to 2023.
Future trends to watch for include advancements in antibiotic resistance management and evolving pharmaceutical regulations, which may impact market demand and pricing.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | |||
| 6 | 6 Australia | 10.14 | 2023 | View data | ||
| 7 | 7 Canada | 7.4 | 2023 | View data | ||
